Chemoinformaics analysis of Acetylatractylodinol
| Molecular Weight | 240.258 | nRot | 3 |
| Heavy Atom Molecular Weight | 228.162 | nRig | 10 |
| Exact Molecular Weight | 240.079 | nRing | 1 |
| Solubility: LogS | -3.17 | nHRing | 1 |
| Solubility: LogP | 3.384 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 5 |
| nHA | 3 | APOL | 35.4575 |
| nHD | 0 | BPOL | 16.3785 |
| QED | 0.601 |
| Synth | 3.412 |
| Natural Product Likeliness | 1.413 |
| NR-PPAR-gamma | 0.213 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.13 |
| Pgp-sub | 0.001 |
| HIA | 0.144 |
| CACO-2 | -4.302 |
| MDCK | 0.0000236 |
| BBB | 0.007 |
| PPB | 1.00727 |
| VDSS | 2.865 |
| FU | 0.0203997 |
| CYP1A2-inh | 0.991 |
| CYP1A2-sub | 0.089 |
| CYP2c19-inh | 0.952 |
| CYP2c19-sub | 0.152 |
| CYP2c9-inh | 0.954 |
| CYP2c9-sub | 0.493 |
| CYP2d6-inh | 0.923 |
| CYP2d6-sub | 0.19 |
| CYP3a4-inh | 0.892 |
| CYP3a4-sub | 0.327 |
| CL | 5.979 |
| T12 | 0.767 |
| hERG | 0.064 |
| Ames | 0.722 |
| ROA | 0.943 |
| SkinSen | 0.966 |
| Carcinogencity | 0.453 |
| EI | 0.97 |
| Respiratory | 0.929 |
| NR-Aromatase | 0.852 |
| Antiviral | Yes |
| Prediction | 0.5672 |